RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group
2008-01-01 Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group
2008-01-01 Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl
1,25-Dihydroxyvitamin D3-mediated inhibition of human leukemic B cell precursors
1992-01-01 Consolini, Rita; Pala, S; Petrini, Mario; Matii, L; Macchia, P.
90y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group
2008-01-01 Carella, Am; Nati, S; Fraternali Orcioni, G; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, P. L.
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL.
2012-01-01 Galimberti, Sara; Polillo, M; Baratè, C; Guerrini, Francesca; Cervetti, G; Capecchi, M; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases
2007-01-01 Focosi, D; Galimberti, Sara; Petrini, Mario
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT
2015-01-01 Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M.
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT
2015-01-01 Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M.
Age-Dependent Influence of TNF-{alpha} Polymorphism on Progression Free Survival of ASCT In Multiple Myeloma Patients
2010-01-01 Buda, Gabriele; Martino, A; Orciuolo, E; Maggini, Valentina; Lapi, F; Galimberti, Sara; Barale, Roberto; Rossi, ANNA MARIA; Petrini, Mario
Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis.
2009-01-01 Pelosini, M; Baronti, F; Caracciolo, F; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Orciuolo, E; Buda, G; Starita, A; Petrini, Mario
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group | 1-gen-2008 | Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl | |
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group | 1-gen-2008 | Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl | |
1,25-Dihydroxyvitamin D3-mediated inhibition of human leukemic B cell precursors | 1-gen-1992 | Consolini, Rita; Pala, S; Petrini, Mario; Matii, L; Macchia, P. | |
90y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group | 1-gen-2008 | Carella, Am; Nati, S; Fraternali Orcioni, G; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, P. L. | |
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. | 1-gen-2012 | Galimberti, Sara; Polillo, M; Baratè, C; Guerrini, Francesca; Cervetti, G; Capecchi, M; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello | |
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases | 1-gen-2007 | Focosi, D; Galimberti, Sara; Petrini, Mario | |
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT | 1-gen-2015 | Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M. | |
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT | 1-gen-2015 | Iovino, L; Caracciolo, F.; Orciuolo, E.; Buda, G.; Mazziotta, F.; Rousseau, M.; Galimberti, S.; Benedetti, E.; Petrini, M. | |
Age-Dependent Influence of TNF-{alpha} Polymorphism on Progression Free Survival of ASCT In Multiple Myeloma Patients | 1-gen-2010 | Buda, Gabriele; Martino, A; Orciuolo, E; Maggini, Valentina; Lapi, F; Galimberti, Sara; Barale, Roberto; Rossi, ANNA MARIA; Petrini, Mario | |
Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis. | 1-gen-2009 | Pelosini, M; Baronti, F; Caracciolo, F; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Orciuolo, E; Buda, G; Starita, A; Petrini, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 101
- 1 Contributo su Rivista::1.5 Abst... 101
Data di pubblicazione
- 2010 - 2020 48
- 2000 - 2009 49
- 1990 - 1999 4
Rivista
- BLOOD 35
- HAEMATOLOGICA 33
- BONE MARROW TRANSPLANTATION 13
- HAEMATOLOGICA 7
- BONE MARROW TRANSPLANTATION 4
- AMERICAN JOURNAL OF CLINICAL ONCO... 2
- ANNALS OF THE RHEUMATIC DISEASES 1
- BLOOD REVIEWS 1
- CYTOMETRY. PART A 1
- EUROPEAN SURGICAL RESEARCH 1
Keyword
- immune reconstitution 3
- immunotherapy 2
- T-lymphocytes 2
- thymus 2
- zinc 2
- 10 patients died all due to progr... 1
- 27 a partial remission considerin... 1
- 28 with 70 mg/m2 and 5 with 120 m... 1
- 3 relapsed and 28 with disease un... 1
- 31 in continuous complete remission 1
Lingua
- eng 71
Accesso al fulltext
- no fulltext 96
- open 4
- restricted 1